TransMedics Group, Inc. (TMDX)

NGM – Real Time Price. Currency in USD

87.46

-1.90 (-2.13%)

Market open: Aug 12, 2026, 2:07 PM EDT

88.50

-0.86 (-0.96%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

605M

442M

242M

93M

Cost of goods sold

-243M

-180M

-88M

-28M

Gross Profit

363M

262M

154M

65M

Operating expenses (excl. COGS)

-254M

-224M

-154M

-97M

Operating Income

109M

37M

485K

-31M

Non-operating income, total

-1M

-2M

-27M

-5M

Pretax income

108M

36M

-27M

-36M

Equity in earnings

Taxes

83M

-316K

-66K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

190M

35M

-25M

-36M

Discontinued operations

Net income

190M

35M

-25M

-36M

Dilution adjustment

Preferred dividends

TransMedics Group, Inc. (TMDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TransMedics Group, Inc. (TMDX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

TransMedics Group, Inc. (TMDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TransMedics Group, Inc. (TMDX)

Income Statement (Annual)

Income Statement (Annual)